{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:04:56Z","timestamp":1783393496078,"version":"3.54.6"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2025.1712601","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:31:19Z","timestamp":1761111079000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Current chemical approaches in combating neuroinflammation in Alzheimer's disease (AD)"],"prefix":"10.3389","volume":"17","author":[{"given":"Sayan Roy","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwaipayan","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasenjit","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers. Dement."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2025.5640","article-title":"GLP-1 medications may lower dementia risk, research shows","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3233\/JAD-221010","article-title":"Cerebrospinal fluid sTREM-2, GFAP, and beta-S100 in symptomatic sporadic Alzheimer's disease: microglial, astrocytic, and APOE contributions along the Alzheimer's disease continuum","volume":"92","author":"Bonomi","year":"2023","journal-title":"J. Alzheimers Di"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01374-9","article-title":"IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine","volume":"23","author":"Chen","year":"2022","journal-title":"J. Headache Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nyas.12987","article-title":"Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration","volume":"1363","author":"Figueiredo-Pereira","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.14336\/AD.2020.0827","article-title":"Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death","volume":"12","author":"Gennaccaro","year":"2021","journal-title":"Aging Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"24","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1007\/s12035-017-0533-3","article-title":"Synaptic dysfunction in Alzheimer's disease: abeta, tau, and epigenetic alterations","volume":"55","author":"Li","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2304545","DOI":"10.1002\/advs.202304545","article-title":"Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer's disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1021\/acschemneuro.8b00253","article-title":"Peptide-based acetylcholinesterase inhibitor crosses the blood-brain barrier and promotes neuroprotection","volume":"9","author":"Mondal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2967\/jnumed.114.141713","article-title":"Imaging microglial activation with TSPO PET: lighting up neurologic diseases?","volume":"57","author":"Vivash","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41593-023-01561-8","article-title":"Somatosensory cortex and central amygdala regulate neuropathic pain-mediated peripheral immune response via vagal projections to the spleen","volume":"27","author":"Zhu","year":"2024","journal-title":"Nat. Neurosci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1712601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:31:19Z","timestamp":1761111079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1712601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":15,"alternative-id":["10.3389\/fnagi.2025.1712601"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1712601","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1712601"}}